Latest Market News
Regulated companies that produce or sell financial instruments must meet the MiFID II requirements as regards product governance. These rules differ depending on the role played by the companies in this area. The FSMA wishes to help companies comply with these new product governance requirements by offering them a work programme (available in French or Dutch only). […]
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of ASIT Biotech, ISIN BE0974289218, on Euronext Brussels is suspended on the request of the company from 17/03/2021 at 09:00 CET until the publication of a press release. […]
The FSMA is launching a series of animated films (available in French and Dutch only) about the rules intended to combat money-laundering and terrorist financing. The films are intended to help insurance intermediaries to apply these rules correctly. Via these new films, the FSMA seeks to raise the awareness of insurance intermediaries active in the […]
Mr Jean-Paul Servais, the Chairman of the FSMA, delivered the closing keynote at the yearly EU-Asia Financial Services Dialogue organised by Asifma and Afore, in which more than 450 persons participated digitally. His remarks focused on the recent developments in the international landscape for sustainable finance and sustainability disclosures by public companies. Mr Servais is […]
The FSMA is authorized, pursuant to Article 29, §1, n) of the Law of 11 July 2018 on public offers of investment instruments and the admission to trading of investment instruments on a regulated market (hereafter the ‘Prospectus Law’), to disclose to the public any decision it has made in accordance with Article 29, §1, […]
The FSMA is authorized, pursuant to Article 29, § 1, n) of the Law of 11 July 2018 on the public offer of investment instruments and the admission of investment instruments to trading on a regulated market (hereafter the ‘Prospectus Law’), to disclose to the public any decision it has made in accordance with Article […]